Latest / Decera Clinical Education Oncology Podcast
Practical Insights on Key Data From ESMO 2020 Informing Precision Medicine in NSCLC
In this episode, Helena A. Yu, MD, and Maria E. Arcila, MD, provide medical oncology and pathology perspectives, respectively, on new data from ESMO 2020 informing precision medicine in NSCLC, with topics including:
Updated efficacy data from the phase III ADAURA study of adjuvant osimertinib for resected EGFR-mutated NSCLC with a focus on CNS disease recurrence
Biomarker testing in early-stage lung cancer
New data for sotorasib, a small molecule inhibitor of KRAS G12C, in heavily pretreated NSCLC
Interim results from the phase I portion of the CHRYSALIS trial evaluating amivantamab, a…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.